Cancer Incidence for Riverdale, Fieldston & Kingsbridge, Bronx County, 2016-2020
Source: New York State Cancer Registry
Site of Cancer | Males and Females | Males | Females | ||||||
---|---|---|---|---|---|---|---|---|---|
Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | |
All Invasive Malignant Tumors | 609.4 | 401.9 | 387.0-417.3 | 283.8 | 434.3 | 411.3-458.3 | 325.6 | 384.0 | 364.2-404.7 |
Oral cavity and pharynx | 14.2 | 9.5 | 7.3-12.2 | 10.4 | 16.5 | 12.1-21.9 | 3.8 | 4.0 | 2.3-6.6 |
Esophagus | 3.2 | 2.0 | 1.1-3.4 | 1.6 | 2.5 | 1.1-5.1 | 1.6 | 1.6 | 0.6-3.5 |
Stomach | 10.6 | 7.0 | 5.2-9.4 | 6.8 | 10.9 | 7.4-15.4 | 3.8 | 4.4 | 2.5-7.2 |
Colorectal | 49.8 | 32.9 | 28.7-37.6 | 23.6 | 38.3 | 31.4-46.2 | 26.2 | 28.7 | 23.5-34.7 |
Colon excluding rectum | 36.0 | 23.2 | 19.7-27.2 | 16.2 | 26.3 | 20.7-33.0 | 19.8 | 20.7 | 16.5-25.8 |
Rectum & rectosigmoid | 13.8 | 9.6 | 7.4-12.4 | 7.4 | 12.0 | 8.3-16.8 | 6.4 | 7.9 | 5.3-11.6 |
Liver / intrahepatic bile duct | 18.2 | 11.4 | 9.1-14.2 | 11.8 | 17.5 | 13.2-22.8 | 6.4 | 7.0 | 4.7-10.2 |
Pancreas | 19.8 | 11.3 | 9.0-13.9 | 11.2 | 16.5 | 12.4-21.7 | 8.6 | 7.4 | 5.2-10.5 |
Larynx | 3.6 | 2.2 | 1.3-3.6 | 2.8 | 4.0 | 2.2-6.9 | 0.8 | 1.0 | 0.3-2.7 |
Lung and bronchus | 57.4 | 34.4 | 30.4-38.9 | 27.0 | 39.2 | 32.8-46.7 | 30.4 | 30.9 | 25.9-36.6 |
Melanoma of the skin | 15.6 | 10.1 | 7.9-12.8 | 8.6 | 14.0 | 10.0-19.1 | 7.0 | 7.3 | 4.9-10.6 |
Female breast | 100.2 | 126.5 | 114.9-139.0 | ||||||
Cervix uteri | 4.4 | 6.8 | 4.2-10.6 | ||||||
Corpus uterus and NOS | 25.2 | 28.7 | 23.7-34.5 | ||||||
Ovary | 10.6 | 13.4 | 9.9-17.9 | ||||||
Prostate | 79.6 | 116.4 | 105.0-128.7 | ||||||
Testis | 2.4 | 4.6 | 2.3-8.2 | ||||||
Urinary bladder (incl. in situ) | 22.8 | 13.5 | 11.0-16.4 | 16.8 | 24.5 | 19.4-30.6 | 6.0 | 6.1 | 4.0-9.0 |
Kidney and renal pelvis | 18.4 | 12.1 | 9.7-15.1 | 11.6 | 17.5 | 13.2-22.9 | 6.8 | 8.4 | 5.6-12.1 |
Brain and other central nervous system | 9.2 | 6.8 | 4.9-9.3 | 5.6 | 9.4 | 6.1-13.8 | 3.6 | 4.9 | 2.7-8.2 |
Thyroid | 20.8 | 17.1 | 13.8-20.8 | 3.0 | 5.7 | 3.1-9.5 | 17.8 | 26.6 | 21.1-33.1 |
Hodgkin lymphoma | 3.0 | 2.8 | 1.5-4.6 | 0.6 | 1.2 | 0.2-3.6 | 2.4 | 4.3 | 2.1-7.5 |
Non-Hodgkin lymphomas | 25.8 | 16.9 | 13.9-20.4 | 14.0 | 21.5 | 16.6-27.5 | 11.8 | 13.9 | 10.3-18.4 |
Myeloma | 16.0 | 10.0 | 7.9-12.7 | 8.2 | 12.0 | 8.5-16.5 | 7.8 | 8.8 | 6.1-12.3 |
Leukemias | 19.0 | 12.8 | 10.1-15.9 | 10.2 | 16.6 | 12.2-22.2 | 8.8 | 9.9 | 7.0-13.8 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYC neighborhoods were defined in terms of Public Use Microdata Areas (PUMAs). PUMAs approximate NYC Community Districts (CDs).
- For more information about PUMAs, please refer to http://www1.nyc.gov/site/planning/data-maps/nyc-population/geographic-reference.page.